Inter-relationships between airway inflammation, reticular basement membrane thickening and bronchial hyper-reactivity to methacholine in asthma; a systematic bronchoalveolar lavage and airway biopsy analysis

Clinical and Experimental Allergy

Volumn 35, Issue 12, 2005, Pages 1565-1571

  Ward, C ^a,d   Reid, D W ^b   Orsida, B E ^c   Feltis, B ^b   Ryan, V A ^a   Johns, D P ^b   Walters, E H ^b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF TASMANIA   (Australia)

^c MONASH UNIVERSITY MEDICAL SCHOOL   (Australia)

^d Hospital   (United Kingdom)

Author keywords

Airway remodelling; Asthma; Inflammation

Indexed keywords

CORTICOSTEROID; FLUTICASONE PROPIONATE; METHACHOLINE; BRONCHOCONSTRICTING AGENT; DIAGNOSTIC AGENT; METHACHOLINE CHLORIDE; RETICULIN;

ADOLESCENT; ADULT; AIRWAY; ARTICLE; ASTHMA; BASEMENT MEMBRANE; BRONCHUS HYPERREACTIVITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG MEGADOSE; EOSINOPHIL COUNT; EPITHELIUM CELL; FEMALE; HUMAN; INFLAMMATORY CELL; LUNG LAVAGE; MALE; MAST CELL; PRIORITY JOURNAL; RESPIRATORY TRACT BIOPSY; RETICULAR BASEMENT MEMBRANE; BIOPSY; BRONCHUS; CASE CONTROL STUDY; CHEMICALLY INDUCED DISORDER; CHEMISTRY; HYPERSENSITIVITY; IMMUNOLOGY; INHALATION TEST; PATHOLOGY; REGRESSION ANALYSIS; SPIROMETRY;

ASTHMA; BASEMENT MEMBRANE; BIOPSY; BRONCHI; BRONCHIAL HYPERREACTIVITY; BRONCHIAL PROVOCATION TESTS; BRONCHOALVEOLAR LAVAGE FLUID; BRONCHOCONSTRICTOR AGENTS; CASE-CONTROL STUDIES; HUMANS; HYPERSENSITIVITY; METHACHOLINE CHLORIDE; REGRESSION ANALYSIS; RETICULIN; SPIROMETRY;

EID: 33646192385     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2005.02365.x     Document Type: Article

References (24)

1. Bousquet J Jeffery PK Busse WW Johnson M Vignola AM. Asthma. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med 2000 161 : 1720 45.
2. Roche WR Beasley R Williams JH Holgate ST. Subepithelial fibrosis in the bronchi of asthmatics. Lancet 1989 1 : 520 4.
3. Jeffery PK Godfrey RW Adelroth E Nelson F Rogers A Johansson SA. Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma. A quantitative light and electron microscopic study. Am Rev Respir Dis 1992 145 (Part 1) : 890 9.
4. Orsida BE Ward C Li X et al. Effect of a long-acting beta2-agonist over three months on airway wall vascular remodeling in asthma. Am J Respir Crit Care Med 2001 164 : 117 21.
5. Tattersfield AE Knox AJ Britton JR Hall IP. Asthma. Lancet 2002 360 : 1313 22.
6. Fish JE Peters SP. Airway remodeling and persistent airway obstruction in asthma. J Allergy Clin Immunol 1999 104 (Part 1) : 509 16.
7. Elias JA. Airway remodeling in asthma. Unanswered questions. Am J Respir Crit Care Med 2000 161 (Part 2) : S168 71.
8. Pedersen S. Why does airway inflammation persist? Is it failure to treat early? Am J Respir Crit Care Med 2000 161 (Part 2) : S182 5.
9. Ward C Johns DP Bish R et al. Reduced airway distensibility, fixed Airflow limitation, and airway wall remodeling in asthma. Am J Respir Crit Care Med 2001 164 : 1718 21.
10. Ward C Pais M Bish R et al. Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma. Thorax 2002 57 : 309 16.
11. Carroll NG Perry S Karkhanis A et al. The airway longitudinal elastic fiber network and mucosal folding in patients with asthma. Am J Respir Crit Care Med 2000 161 : 244 8.
12. Kasahara K Shiba K Ozawa T Okuda K Adachi M. Correlation between the bronchial subepithelial layer and whole airway wall thickness in patients with asthma. Thorax 2002 57 : 242 6.
13. Wiggs BR Bosken C Pare PD James A Hogg JC. A model of airway narrowing in asthma and in chronic obstructive pulmonary disease [see comments]. Am Rev Respir Dis 1992 145 : 1251 8.
14. Wiggs BR Hrousis CA Drazen JM Kamm RD. On the mechanism of mucosal folding in normal and asthmatic airways. J Appl Physiol 1997 83 : 1814 21.
15. Hoshino M Takahashi M Takai Y Sim J Aoike N. Inhaled corticosteroids decrease vascularity of the bronchial mucosa in patients with asthma. Clin Exp Allergy 2001 31 : 722 30.
16. Orsida BE Li X Hickey B Thien F Wilson JW Walters EH. Vascularity in asthmatic airways: relation to inhaled steroid dose [see comments]. Thorax 1999 54 : 289 95.
17. Laitinen LA Laitinen A Altraja A et al. Bronchial biopsy findings in intermittent or "early" asthma. J Allergy Clin Immunol 1996 98 (Part 2) : S3 6 discussion S33-40.
18. Niimi A Matsumoto H Minakuchi M Kitaichi M Amitani R. Airway remodelling in cough-variant asthma [letter]. Lancet 2000 356 : 564 5.
19. Holgate ST. The role of mast cells and basophils in inflammation. Clin Exp Allergy 2000 30 (Suppl. 1) : 28 32.
20. Brightling CE Bradding P Symon FA Holgate ST Wardlaw AJ Pavord ID. Mast-cell infiltration of airway smooth muscle in asthma. N Engl J Med 2002 346 : 1699 705.
21. Flood-Page P Menzies-Gow A Phipps S et al. Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics. J Clin Invest 2003 112 : 1029 36.
22. Davies DE Holgate ST. Asthma: the importance of epithelial mesenchymal communication in pathogenesis. Inflammation and the airway epithelium in asthma. Int J Biochem Cell Biol 2002 34 : 1520 6.
23. Van Eerdewegh P Little RD Dupuis J et al. Association of the ADAM33 gene with asthma and bronchial hyperresponsiveness. Nature 2002 418 : 426 30.
24. Shapiro SD Owen ADAM-33 Surfaces as an Asthma Gene. N Engl J Med 2002 347 : 936 8.